Skip to Content

Lannett 1778 20 mg (Temozolomide 20 mg)

Pill with imprint Lannett 1778 20 mg is Orange & White, Capsule-shape and has been identified as Temozolomide 20 mg. It is supplied by Lannett Company, Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lannett 1778 20 mg

Temozolomide

Imprint
Lannett 1778 20 mg
Strength
20 mg
Color
Orange & White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lannett Company, Inc.
National Drug Code (NDC)
00527-1778
Inactive Ingredients
mannitol, croscarmellose sodium, stearic acid, citric acid anhydrous, silicon dioxide, sodium lauryl sulfate, gelatin, titanium dioxide, ferric oxide yellow, ferric oxide red, shellac, alcohol, ferrosoferric oxide, butyl alcohol, propylene glycol, methyl alcohol, FD&C Blue No. 2, FD&C Red No. 40, FD&C Blue No. 1, D&C Yellow No. 10, aluminum oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.